Acuitas provides delivery solutions for molecular therapeutics using lipid nanoparticles (LNP)
Acuitas is a biotechnology company that works with partners and customers to develop new or improved medicines based on our internationally recognized capabilities in nanotechnology-based pharmaceutical product development.
Our key capabilities include:
- Proven ability to design and synthesize key LNP components
- In vivo screening to select LNP therapeutic candidates
- State of the art models to characterize LNP therapeutics
- Experienced staff to advance products from R&D into clinical development
- Excellent communication and project management skills
